Victory Capital Management Inc Rapt Therapeutics, Inc. Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$15.89 - $40.87 $1.01 Million - $2.6 Million	-63,640 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$21.6 - $37.5 $610,848 - $1.06 Million	28,280 Added 79.98%	63,640 $2.05 Million
Q2 2020 Aug 07, 2020	SELL	$14.16 - $32.85 $1.21 Million - $2.82 Million	-85,703 Reduced 70.79%	35,360 $1.03 Million
Q1 2020 May 04, 2020	BUY	$11.86 - $48.86 $1.42 Million - $5.86 Million	119,850 Added 9880.46%	121,063 $2.58 Million
Q4 2019 Feb 04, 2020	BUY	$12.3 - $30.78 $14,919 - $37,336	1,213 New	1,213 $54,000

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $32.3M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.